SCHEMBL8726196

SCHEMBL8726196

CC(C)(C)OC(=O)[C@@H](N)CCC(=O)OC(=O)Cc1ccc(N(CCCl)CCCl)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.46
ALDH1A1 P00352 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HIF1A Q16665 3/20 0.46
LMNA P02545 3/20 0.46
KMT2A Q03164 3/20 0.46
ALOX15 P16050 2/20 0.46
NFKB1 P19838 2/20 0.46
THPO P40225 2/20 0.46
MAPT P10636 2/20 0.46
PMP22 Q01453 2/20 0.46
MEN1 O00255 2/20 0.46
ABCB11 O95342 1/20 0.46
CHRM2 P08172 1/20 0.46
ADRA2A P08913 1/20 0.46
CHRM1 P11229 1/20 0.46
ACHE P22303 1/20 0.46
PTGS1 P23219 1/20 0.46
OPRM1 P35372 1/20 0.46
DRD3 P35462 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23394728 0.81 CYP3A4 (0.65) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL7906473 0.76 KMT2A (0.52) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL12102434 0.75 EGFR (0.49) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL9296949 0.75 CYP3A4 (0.60) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL1056862 0.74 CYP3A4 (0.46) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL7902174 0.72 CYP3A4 (0.37) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL7465257 0.70 CYP4F2 (0.51) CYP3A4ALDH1A1SMN1; SMN2HIF1ALMNA
SCHEMBL9751830 0.69 EGFR (0.45) LMNAHDAC6EGFRERBB2
SCHEMBL9250356 0.69 LTA4H (0.43) KMT2AALOX15PMP22MEN1CYP1A2
SCHEMBL17941638 0.69 LTA4H (0.40) LTA4HHDAC6HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0651740-B1 AMINO ACID LINKED NITROGEN MUSTARD DERIVATIVES AND THEIR USE AS PRODRUGS IN THE TREATMENT OF TUMOURS ZENECA LTD (GB) 1998-10-21 EP disclosed